In this Issue
Do our genes hold the cure?
Medical Editors’ Page
By Allen C. Ho, MD; and Robert L. Avery, MD
Favorite moments and tidbits from the 2018 ASRS annual meeting.
By Durga Borkar, MD; Philip Storey, MD; and Daniel Su, MD
Several surgical methods have been proposed to manage this rare condition.
By Zachary Bodnar, MD; and Prithvi Mruthyunjaya, MD, MHS
Some patients who do not respond to anti-VEGF therapy may benefit from surgical intervention.
By Emiliano Di Carlo, MD; and Albert J. Augustin, MD
Indocyanine green–enhanced transpupillary thermotherapy was an effective treatment for this patient.
By Lin Liu, MD; Babak Masoomian, MD; and Carol L. Shields, MD
By Vishal Agrawal, MD, FRCS; Maya Hada, MD; Kamlesh Khilnani, MS; and Isha Lohmror, MS
“Classical Gas” meets “Rocky Mountain High” and “Leaving on a Jet Plane.”
By Brian C. Joondeph, MD, MPS
Surveying the landscape of gene therapy trials for inherited retinal diseases.
By Benjamin Bakall, MD, PhD
One gene therapy for IRDs is on the market, and many more are in trials. Are acquired retinal disorders the next target?
By Szilárd Kiss, MD
The development of therapies for orphan retinal diseases and genetic disorders differs from that of traditional treatments.
By Thomas Ciulla, MD, MBA
The treatment landscape for inherited retinal diseases is changing.
By Christine Kay, MD
SUBFOCUS: THE DIAGNOSIS & TREATMENT OF UVEITIS
Many options for use in diagnosing and treating patients with inflammatory conditions.
By Parisa Emami-Naeini, MD; and Sumit Sharma, MD
A brief examination of the role of vitrectomy in diagnosing and treating uveitis.